Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
71,152.77
(
-2.64%
)
News Focus
News Focus
Post# of 517118
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

rx7171

Send PM Follow Ignore
Followers 3
Posts 743
Boards Moderated 0
Alias Born 07/16/2006

rx7171

Re: 123tom post# 508254

Saturday, 11/15/2025 2:47:29 AM

Saturday, November 15, 2025 2:47:29 AM

Post# of 517118
I assume the OLE data will be excluded because it was not blinded and not described as part of the Phase 2b/3 trial.

However the data from the 48 week trial has been refined through precision genomic based analysis to produce the ABCLEAR1-3 data which is outstanding.
Not new data just a better focus on its details.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News